← Insiders

CHD

Neutral signalScored 2026-08-26 Drivers: Congress, fundamentals. Moteurs : Congrès, fondamentaux.

Research, not advice.

À propos

Church & Dwight Co., Inc.

Nom
Church & Dwight Co., Inc.
Secteur
Consumer Defensive
Industrie
Household & Personal Products
Bourse
NYSE
Capitalisation
$25.0B
Employés
5,550
PDG
Richard A. Dierker
Site web
https://www.churchdwight.com
Marché
CLCLXETTYFHENOYKAOCFKMB

Church & Dwight Co., Inc. is a company dedicated to the creation, production, and marketing of a diverse portfolio encompassing household, personal care, and specialized industrial goods. Its operations are structured into three principal divisions: Consumer Domestic, Consumer International, and the Specialty Products Division. The company offers a broad array of well-known consumer brands. Under the ARM & HAMMER umbrella, it provides cat litters, carpet fresheners, laundry detergents, baking soda, and various other baking soda-based items. Sexual health products, including condoms, lubricants, and vibrators, are marketed under the TROJAN brand. OXICLEAN delivers stain removers, cleaning solutions, laundry detergents, and bleach alternatives. SPINBRUSH offers both battery-operated and manual toothbrushes. Home pregnancy and ovulation test kits are available through FIRST RESPONSE. NAIR specializes in depilatories, while ORAJEL provides oral pain relief. XTRA is another prominent laundry detergent brand. Gummy dietary supplements are sold under the L'IL CRITTERS and VITAFUSION labels. BATISTE is known for its dry shampoos. WATERPIK manufactures water flossers and replacement showerheads. The company also includes its FLAWLESS range of products, ZICAM for cold symptom relief, and THERABREATH for oral care. Beyond consumer items, Church & Dwight supplies specialty products. These include advanced animal productivity solutions such as MEGALAC, a rumen bypass fat supplement designed to help cows sustain energy during peak milk production. BIO-CHLOR and FERMENTEN are utilized to mitigate health issues linked to calving and to provide essential protein. CELMANAX is a refined functional carbohydrate and yeast-based prebiotic. Furthermore, the company furnishes sodium bicarbonate for industrial use, as well as various cleaning and deodorizing compounds. Church & Dwight distributes its consumer goods through an extensive network of retail outlets, including supermarkets, large department stores, wholesale clubs, drugstores, convenience stores, home goods stores, dollar and other discount retailers, pet stores, specialized shops, and various online e-commerce channels. Its specialty products, conversely, reach industrial clients and livestock producers via dedicated distributors. Founded in 1846, Church & Dwight Co., Inc. maintains its corporate headquarters in Ewing, New Jersey.

Price (1 year)

Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.

VENTE TOTALE: 17 500 titres (~1 798 884,97 $ US)

Insiders
IRWIN BRADLEY CWINKLEBLACK ARTHUR B
Total bought
—

Avg buy (VWAP, 90d window) —

Total sold
$5,462,035

Avg sell (VWAP, 90d window) $102.57 vs last close —

Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.

Last activity
2026-08-11
Last synced
2026-08-21 23:36:53 Synced via automated research pipeline

Sign in to request a sync of this company's price history and timing levels.

Insider holdings as a share of total assets aren't available for this company.

Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.

Recent Form 4

Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.

Date Person Side Shares Price Value Form 4
2026-08-26 Linares Carlos G. Sell · S 15,375 $103.00 $1,583,625 Form 4
2026-08-25 Hemsey Rene Sell · S 5,000 $102.25 $511,275 Form 4
2026-08-24 Linares Carlos G. Sell · S 15,375 $102.00 $1,568,250 Form 4
2026-08-11 IRWIN BRADLEY C Sell · S 4,300 $102.69 $441,575 Form 4
2026-08-05 WINKLEBLACK ARTHUR B Sell · S 13,200 $102.83 $1,357,310 Form 4

Congressional trades

STOCK Act disclosures (90-day window)

Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.

No STOCK Act disclosures for this company in this window.

Recent trades

DateRepresentativeTypeAmount
2025-10-10Richard W. AllenSale$15,001 - $50,000
2025-09-29Ro KhannaPurchase$1,001 - $15,000
2025-09-25Lisa McClainSale (Full)$1,001 - $15,000
2025-08-04Lisa McClainPurchase$1,001 - $15,000
2025-08-04Ro KhannaPurchase$1,000 - $15,000
2025-06-24Lisa McClainSale (Full)$1,001 - $15,000
2025-06-17Lisa McClainPurchase$1,001 - $15,000
2025-05-14Jonathan JacksonSale$15,001 - $50,000
2025-05-05Jonathan JacksonSale$1,001 - $15,000
2025-04-23Jonathan JacksonPurchase$1,001 - $15,000
2025-03-24Jonathan JacksonPurchase$1,001 - $15,000
2025-03-03Jonathan JacksonPurchase$1,001 - $15,000
2024-11-13Jonathan JacksonPurchase$15,001 - $50,000
2024-03-20Ro KhannaPurchase$1,001 - $15,000
2024-02-13Ro KhannaSale$1,001 - $15,000
2024-01-10Ro KhannaSale$1,001 - $15,000
2023-02-10Ro KhannaPurchase$1,001 - $15,000
2022-11-02Ro KhannaSale$1,001 - $15,000
2022-09-29Ro KhannaPurchase$1,001 - $15,000
2022-08-01Ro KhannaPurchase$1,001 - $15,000
2022-06-17Ro KhannaSale$1,001 - $15,000
2022-06-16Ro KhannaSale$15,001 - $50,000
2022-05-23Ro KhannaPurchase$15,001 - $50,000
2021-11-18Peter WelchSale (Full)$15,001 - $50,000
2021-03-10Richard W. AllenSale (Full)$15,001 - $50,000
2021-03-10Richard W. AllenSale (Full)$15,001 - $50,000
2021-01-25Richard W. AllenPurchase$15,001 - $50,000
2020-02-28Peter WelchPurchase$1,001 - $15,000

Signal

Neutral signalScored 2026-08-26 Drivers: Congress, fundamentals. Moteurs : Congrès, fondamentaux.

CHD presents a moderately compelling setup driven by a solid Q2 2026 earnings beat, 5.8% organic sales growth, and raised full-year guidance, supported by improving profitability and cash flow trends.

The first sentence of the analysis written for CHD on 2026-08-26 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.

Neutral signal Drivers: Congress, fundamentals. Moteurs : Congrès, fondamentaux.

Factor checklist — research, not advice

A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.

  • Insider Pulls against a bullish reading. Selling cluster — sale value, no purchase value
  • Congress Supports a bullish reading. 7 purchase disclosures year to date
  • Narrative Unavailable or mixed. Stored narrative reading is in the neutral band
  • Timing Unavailable or mixed. No stored price series
  • Financial indicators Supports a bullish reading. Current ratio 1.07 · operating margin 17%

Market snapshot

Financial ratios

MetricTrend2025-12-312024-12-312023-12-312022-12-312021-12-31
Gross Profit Margin44.7%45.7%44.1%41.9%43.6%
Ebit Margin17.0%13.9%18.4%11.4%20.9%
Ebitda Margin20.9%17.9%22.2%15.5%25.1%
Operating Profit Margin17.4%13.2%18.0%11.1%20.8%
Pretax Profit Margin15.4%12.4%16.5%9.7%19.9%
Continuous Operations Profit Margin11.9%9.6%12.9%7.7%15.9%
Net Profit Margin11.9%9.6%12.9%7.7%15.9%
Bottom Line Profit Margin11.9%9.6%12.9%7.7%15.9%
Current Ratio1.0661.7031.0761.1790.594
Quick Ratio0.7091.2370.6440.6330.336
Solvency Ratio0.2000.1820.2080.1300.220
Cash Ratio0.2730.7330.2420.2280.116
Price To Earnings Ratio27.58243.81230.60247.41830.325
Price To Earnings Growth Ratio1.014-1.9340.374-0.9544.822
Forward Price To Earnings Growth Ratio1.014-1.9340.374-0.9544.822
Price To Earnings Diluted Ratio27.76544.18131.00347.98230.873
Price To Earnings Diluted Growth Ratio1.012-1.9820.380-0.9714.816
Price To Book Ratio5.0855.9286.0075.6117.764
Price To Sales Ratio3.2814.2333.9473.6424.837
Price To Free Cash Flow Ratio18.61926.47828.69327.71828.688
Price To Operating Cash Flow Ratio16.74422.36022.47022.11925.259
Debt To Assets Ratio0.2470.2710.3040.3410.342
Debt To Equity Ratio0.5510.5520.6760.8160.846
Debt To Capital Ratio0.3550.3560.4030.4490.458
Long Term Debt To Capital Ratio0.3550.3360.3640.4270.333
Financial Leverage Ratio2.2272.0372.2232.3912.473
Working Capital Turnover Ratio12.11611.83136.697-17.074-9.285
Operating Cash Flow Ratio0.8120.8790.7250.7480.479
Operating Cash Flow Sales Ratio0.1960.1890.1760.1650.191
Free Cash Flow Operating Cash Flow Ratio0.8990.8440.7830.7980.880
Debt Service Coverage Ratio11.3387.2173.2173.8951.068
Interest Coverage Ratio11.3198.4969.5356.67219.800
Short Term Operating Cash Flow Coverage Ratio0.00035.6854.5109.2301.018
Operating Cash Flow Coverage Ratio0.5510.4810.3960.3110.364
Capital Expenditure Coverage Ratio9.9306.4304.6114.9518.365
Dividend Paid And Capex Coverage Ratio2.9672.5312.1032.0412.713
Dividend Payout Ratio0.3900.4730.3530.6160.299
Enterprise Value Multiple17.04225.03119.50026.63421.141

Sparkline shows each ratio oldest → newest (left → right).

How the latest year compares

For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower

MetricCurrentvs 1Y agovs 5Y avg
Gross Profit Margin 44.7% ▼-0.9% ▲0.7%
Ebit Margin 17.0% ▲3.0% ▲0.6%
Ebitda Margin 20.9% ▲3.1% ▲0.6%
Operating Profit Margin 17.4% ▲4.2% ▲1.3%
Pretax Profit Margin 15.4% ▲3.0% ▲0.6%
Continuous Operations Profit Margin 11.9% ▲2.3% ▲0.3%
Net Profit Margin 11.9% ▲2.3% ▲0.3%
Bottom Line Profit Margin 11.9% ▲2.3% ▲0.3%
Current Ratio 1.066 ▼-0.636 ▼-0.057
Quick Ratio 0.709 ▼-0.527 ▼-0.003
Solvency Ratio 0.200 ▲0.018 ▲0.012
Cash Ratio 0.273 ▼-0.460 ▼-0.045
Price To Earnings Ratio 27.582 ▼-16.230 ▼-8.366
Price To Earnings Growth Ratio 1.014 ▲2.948 ▲0.350
Forward Price To Earnings Growth Ratio 1.014 ▲2.948 ▲0.350
Price To Earnings Diluted Ratio 27.765 ▼-16.416 ▼-8.596
Price To Earnings Diluted Growth Ratio 1.012 ▲2.994 ▲0.361
Price To Book Ratio 5.085 ▼-0.844 ▼-0.994
Price To Sales Ratio 3.281 ▼-0.953 ▼-0.707
Price To Free Cash Flow Ratio 18.619 ▼-7.859 ▼-7.420
Price To Operating Cash Flow Ratio 16.744 ▼-5.616 ▼-5.047
Debt To Assets Ratio 0.247 ▼-0.023 ▼-0.054
Debt To Equity Ratio 0.551 ▼-0.001 ▼-0.137
Debt To Capital Ratio 0.355 ▼-0.000 ▼-0.049
Long Term Debt To Capital Ratio 0.355 ▲0.019 ▼-0.008
Financial Leverage Ratio 2.227 ▲0.190 ▼-0.043
Working Capital Turnover Ratio 12.116 ▲0.285 ▲5.258
Operating Cash Flow Ratio 0.811 ▼-0.067 ▲0.083
Operating Cash Flow Sales Ratio 0.196 ▲0.007 ▲0.013
Free Cash Flow Operating Cash Flow Ratio 0.899 ▲0.055 ▲0.058
Debt Service Coverage Ratio 11.338 ▲4.122 ▲5.991
Interest Coverage Ratio 11.319 ▲2.824 ▲0.155
Short Term Operating Cash Flow Coverage Ratio 0.000 ▼-35.685 ▼-10.089
Operating Cash Flow Coverage Ratio 0.551 ▲0.070 ▲0.131
Capital Expenditure Coverage Ratio 9.930 ▲3.499 ▲3.072
Dividend Paid And Capex Coverage Ratio 2.967 ▲0.436 ▲0.496
Dividend Payout Ratio 0.390 ▼-0.084 ▼-0.036
Enterprise Value Multiple 17.042 ▼-7.989 ▼-4.828

Key metrics

MetricTrend20252024202320222021
Market cap$20.35B$25.85B$23.16B$19.58B$25.10B
Enterprise value$22.15B$27.29B$25.42B$22.16B$27.60B
EV / Sales3.57x4.47x4.33x4.12x5.32x
EV / Op. cash flow18.22x23.61x24.66x25.03x27.77x
EV / Free cash flow20.26x27.95x31.49x31.37x31.54x
EV / EBITDA17.04x25.03x19.50x26.63x21.14x
Net debt / EBITDA1.38x1.32x1.74x3.10x1.91x
Current ratio1.07x1.70x1.08x1.18x0.59x
Income quality1.65x1.98x1.36x2.14x1.20x
Graham number$34$31$33$23$32
Graham net-net-$16-$11-$15-$16-$16
Tax burden77.0%77.4%78.1%79.1%80.2%
Interest burden91.0%88.8%89.7%85.4%95.0%
Working capital$99.3M$924.7M$107.7M$212.1M-$841.8M
Invested capital$7.06B$7.18B$6.77B$6.83B$5.58B
Return on assets8.3%6.6%8.8%5.0%10.3%
Operating ROA12.1%9.2%12.5%7.3%14.0%
Return on tangible assets26.6%16.4%26.6%16.6%37.1%
Return on equity18.4%13.4%19.6%11.9%25.6%
Return on invested capital11.2%8.2%11.2%6.5%12.5%
Return on capital employed14.5%10.7%14.8%8.3%18.2%
Earnings yield3.6%2.3%3.3%2.1%3.3%
Free cash flow yield5.4%3.8%3.5%3.6%3.5%
Capex / Op. cash flow10.1%15.6%21.7%20.2%12.0%
Capex / Depreciation49.5%75.2%113.4%81.6%54.2%
Capex / Sales2.0%2.9%3.8%3.3%2.3%
SG&A / Sales27.4%26.6%26.1%23.1%22.8%
R&D / Sales0.0%0.0%0.0%0.0%0.0%
Stock comp / Sales0.9%1.0%1.1%0.6%0.5%
Intangibles / Total assets68.9%59.9%66.9%70.2%72.1%
Days sales outstanding35d36d33d29d29d
Days payables outstanding78d78d70d78d83d
Operating cycle92d103d101d104d95d
Cash conversion cycle14d26d31d26d13d

Change by theme

Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.

Change over 1 year

Valuation
Market cap ▼-21.3%EV / Sales ▼-20.1%EV / EBITDA ▼-31.9%EV / Op. cash flow ▼-5.385Earnings yield ▲+0.014Graham number ▲+2.869
Profitability
Return on equity ▲+0.050Return on assets ▲+0.017Return on invested capital ▲+0.030Return on capital employed ▲+0.039Operating ROA ▲+0.029Income quality ▼-0.326Tax burden ▼-0.004
Efficiency
Days sales outstanding ▼-0.992Days payables outstanding ▲+0.385Operating cycle ▼-11.542Cash conversion cycle ▼-11.927Capex / Sales ▼-0.010R&D / Sales n/a
Balance-sheet strength
Current ratio ▼-0.636Net debt / EBITDA ▲+0.060Working capital ▼-825400000.000Invested capital ▼-117000000.000Intangibles / Total assets ▲+0.090

Change over 5 years

Valuation
Market cap ▼-18.9%EV / Sales ▼-32.9%EV / EBITDA ▼-19.4%EV / Op. cash flow ▼-9.546Earnings yield ▲+0.003Graham number ▲+1.881
Profitability
Return on equity ▼-0.072Return on assets ▼-0.021Return on invested capital ▼-0.014Return on capital employed ▼-0.037Operating ROA ▼-0.019Income quality ▲+0.449Tax burden ▼-0.032
Efficiency
Days sales outstanding ▲+6.399Days payables outstanding ▼-4.814Operating cycle ▼-3.439Cash conversion cycle ▲+1.375Capex / Sales ▼-0.003R&D / Sales n/a
Balance-sheet strength
Current ratio ▲+0.472Net debt / EBITDA ▼-0.528Working capital ▲+941100000.000Invested capital ▲+1481400000.000Intangibles / Total assets ▼-0.033

Employee count

Peer market caps

Recent news